Genetic variations in the hypoxia-inducible factor-1α gene and lung cancer

Experimental Biology and Medicine

Volumn 234, Issue 9, 2009, Pages 1109-1116

  Konac, Ece ^a   Dogan, Irem ^a   Onen, Hacer Ilke ^a   Yurdakul, Ahmet Selim ^a   Ozturk, Can ^a   Varol, Ayhan ^a   Ekmecki, Abdullah ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

DNA sequencing; HIF 1 ; Lung cancer; Polymorphism; Turkish population

Indexed keywords

DINUCLEOTIDE; GENOMIC DNA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA SEQUENCE; EXON; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRON; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN POLYMORPHISM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION, MISSENSE; POINT MUTATION; POLYMORPHISM, GENETIC; REPETITIVE SEQUENCES, NUCLEIC ACID;

EID: 70349114298     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0902-RM-49     Document Type: Article

References (28)

1. Semenza GL. HIF-1 and human disease: one highly involved factor. Genes Dev 14:1983-1991, 2000.
2. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12:5447-5454, 1992.
3. Koukourakis MI, Papazoglou D, Giatromanolaki A, Panagopoulos I, Maltezos E, Harris AL, Gatter KC, Sivridis E. C2028T polymorphism in exon 12 and dinucleotide repeat polymorphism in intron 13 of the HIF-1alpha gene define HIF-1alpha protein expression in non-small cell lung cancer. Lung Cancer 53(3):257-262, 2006. (Pubitemid 44209281)
4. Prior SJ, Hagberg JM, Phares DA, Brown MD, Fairfull L, Ferrell RE, Roth SM. Sequence variation in hypoxia-inducible factor 1alpha (HIF1A): association with maximal oxygen consumption. Physiol Genomics 15(1):20-26, 2003. (Pubitemid 38089549)
5. Tanimoto K, Yoshiga K, Eguchi H, Kaneyasu M, Ukon K, Kumazaki T, Oue N, Yasui W, Imai K, Nakachi K, Poellinger L, Nishiyama M. Hypoxia-inducible factor-1alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance. Carcinogenesis 24(11):1779-1783, 2003. (Pubitemid 37408141)
6. Ollerenshaw M, Page T, Hammonds J, Demaine A. Polymorphisms in the hypoxia inducible factor-1alpha gene (HIF1A) are associated with the renal cell carcinoma phenotype. Cancer Genet Cytogenet 153(2):122-126, 2004. (Pubitemid 39592144)
7. Kim JH, Jung CW, Cho YH, Lee J, Lee SH, Kim HY, Park J, Park JO, Kim K, Kim WS, Park YS, Im YH, Kang WK, Park K. Somatic VHL alteration and its impact on prognosis in patients with clear cell renal cell carcinoma. Oncol Rep 13(5):859-864, 2005.
8. Fu XS, Choi E, Bubley GJ, Balk SP. Identification of hypoxiainducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation. Prostate 63(3):215-221, 2005. (Pubitemid 40571055)
9. Foley R, Marignol L, Thomas AZ, Cullen IM, Perry AS, Tewari P, O'Grady A, Kay E, Dunne B, Loftus B, Watson RW, Fitzpatrick JM, Woodson K, Lehman T, Hollywood D, Lynch TH, Lawler M. The HIF-1alpha C1772T polymorphism may be associated with susceptibility to clinically localised prostate cancer but not with elevated expression of hypoxic biomarkers. Cancer Biol Ther 8(2):118-124, 2009.
10. Chau CH, Permenter MG, Steinberg SM, Retter AS, Dahut WL, Price DK, Figg WD. Polymorphism in the hypoxia-inducible factor 1alpha gene may confer susceptibility to androgen-independent prostate cancer. Cancer Biol Ther 4(11):1222-1225, 2005.
11. Fransén K, Fenech M, Fredrikson M, Dabrosin C, Söderkvist P. Association between ulcerative growth and hypoxia inducible factor-1alpha polymorphisms in colorectal cancer patients. Mol Carcinog 45(11):833-840, 2006. (Pubitemid 44646335)
12. Konac E, Onen HI, Metindir J, Alp E, Biri AA, Ekmekci A. An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers. Cancer Detect Prev 31(2):102-109, 2007. (Pubitemid 46680371)
13. Kim HO, Jo YH, Lee J, Lee SS, Yoon KS. The C1772T genetic polymorphism in human HIF-1alpha gene associates with expression of HIF-1alpha protein in breast cancer. Oncol Rep 20(5):1181-1187, 2008.
14. Kuwai T, Kitadai Y, Tanaka S, Kuroda T, Ochiumi T, Matsumura S, Oue N, Yasui W, Kaneyasu M, Tanimoto K, Nishiyama M, Chayama K. Single nucleotide polymorphism in the hypoxia-inducible factor-1alpha gene in colorectal carcinoma. Oncol Rep 12(5):1033-1037, 2004.
15. Ling TS, Shi RH, Zhang GX, Zhu H, Yu LZ, Ding XF. Common single nucleotide polymorphism of hypoxia-inducible factor-1alpha and its impact on the clinicopathological features of esophageal squamous cell carcinoma. Chin J Dig Dis 6(4):155-158, 2005. (Pubitemid 43918439)
16. Li H, Bubley GJ, Balk SP, Gaziano JM, Pollak M, Stampfer MJ, Ma J. Hypoxia-inducible factor-1alpha (HIF-1alpha) gene polymorphisms, circulating insulin-like growth factor binding protein (IGFBP)-3 levels and prostate cancer. Prostate 67(12):1354-1361, 2007. (Pubitemid 47435783)
17. Apaydin I, Konac E, Onen HI, Akbaba M, Tekin E, Ekmekci A. Single nucleotide polymorphisms in the hypoxia-inducible factor-1alpha (HIF-1alpha) gene in human sporadic breast cancer. Arch Med Res 39(3):338-345, 2008. (Pubitemid 351227407)
18. Lee JY, Choi JY, Lee KM, Park SK, Han SH, Noh DY, Ahn SH, Kim DH, Hong YC, Ha E, Yoo KY, Ambrosone CB, Kang D. Rare variant of hypoxia-inducible factor-1alpha (HIF-1A) and breast cancer risk in Korean women. Clin Chim Acta 389(1-2):167-170, 2008.
19. Nadaoka J, Horikawa Y, Saito M, Kumazawa T, Inoue T, Narita S, Yuasa T, Satoh S, Nishiyama H, Ogawa O, Tsuchiya N, Habuchi T. Prognostic significance of HIF-1 alpha polymorphisms in transitional cell carcinoma of the bladder. Int J Cancer 122(6):1297-1302, 2008. (Pubitemid 351287229)
20. Tyczynski JE, Bray F, Aareleid T, Dalmas M, Kurtinaitis J, Plesko I, Pompe-Kirn V, Stengrevics A, Parkin DM. Lung cancer mortality patterns in selected Central, Eastern and Southern European countries. Int J Cancer 109(4):598-610, 2004. (Pubitemid 38339652)
21. Perera FP. Environment and cancer: who are susceptible? Science 278(5340):1068-1073, 1997.
22. Raymond M, Rousset F. GENEPOP (version 4.0): an updated version of GENEPOP (version 1.2): population genetics software for exact tests and ecumenicism. J Hered 86(3):248-249, 1997.
23. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265, 2005. (Pubitemid 40202029)
24. Sole X, Guino E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 22:1928-1929, 2006.
25. Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Talks K, Pezzella F, Gatter KC, Harris AL. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer 85(6):881-890, 2001. (Pubitemid 33010557)
26. Risch A, Plass C. Lung cancer epigenetics and genetics. Int J Cancer 123(1):1-7, 2008.
27. Hlatky MA, Quertermous T, Boothroyd DB, Priest JR, Glassford AJ, Myers RM, Fortmann SP, Iribarren C, Tabor HK, Assimes TL, Tibshirani RJ, Go AS. Polymorphisms in hypoxia inducible factor 1 and the initial clinical presentation of coronary disease. Am Heart J 154(6):1035-1042, 2007. (Pubitemid 350116043)
28. Suzuki K, Kizaki T, Hitomi Y, Nukita M, Kimoto K, Miyazawa N, Kobayashi K, Ohnuki Y, Ohno H. Genetic variation in hypoxia-inducible factor 1alpha and its possible association with high altitude adaptation in Sherpas. Med Hypotheses 61(3):385-389, 2003. (Pubitemid 37100473)